NJ Panel Upholds Elan's $3.4M Tax Bill On Drug Asset Sale
The New Jersey Tax Court properly upheld pharmaceutical giant Elan's $3.4 million tax liability from selling drug assets, a state appeals court said Tuesday, rejecting the company's assertion that the gain...To view the full article, register now.
Already a subscriber? Click here to view full article